Michele Korfin's Insider Trades & SAST Disclosures
Michele Korfin's most recent trade in Organogenesis Holdings Inc - Ordinary Shares - Class A was a trade of 49,575 Class A Common Stock done . Disclosure was reported to the exchange on Feb. 19, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michele Korfin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Organogenesis Holdings Inc... | Michele Korfin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 49,575 | 190,245 (0%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Michele Korfin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 51,020 | 140,670 (0%) | 0% | 0 | Class A Common Stock | |
| Gamida Cell Ltd | Korfin Michele | COO/CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 480,319 | 702,981 | - | 0 | Ordinary Shares | |
| Organogenesis Holdings Inc... | Michele Korfin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 65,737 | 89,650 (0%) | 0% | 0 | Class A Common Stock | |
| Gamida Cell Ltd | Michele Korfin | COO/Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 186,150 | 186,150 | - | - | Employee Share Option (Right to Buy) | |
| Gamida Cell Ltd | Michele Korfin | COO/Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 92,990 | 222,662 | - | 0 | Ordinary Shares | |
| Organogenesis Holdings Inc... | Michele Korfin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 23,913 | 23,913 (0%) | 0% | 0 | Class A Common Stock | |
| Gamida Cell Ltd | Michele Korfin | COO/Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 125,000 | 125,000 | - | - | Employee Share Option (Right to Buy) | |
| Gamida Cell Ltd | Michele Korfin | COO/Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 63,800 | 129,672 | - | 0 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges